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SUMMARY
Objective: Preeclampsia is a pregnancy-specific hypertensive syndrome associated with significant morbidity
and mortality in mother and neonate. We compared neonatal and maternal complications in preeclamptic
women with healthy pregnant women.
Materials and Methods: All 125 consecutive women with preeclampsia at Bandarabbas Shariati Hospital were
assessed between July 2005 and July 2006. Parity, type of delivery, common causes of cesarean section, gesta-
tional age, birth weight, and neonatal complications and mortality were included as study variables and com-
pared with the control group.
Results: Cesarean section rates were significantly higher in the group with preeclampsia than in the control
group (p < 0.05). The mean parity was higher in the normotensive group than in the preeclamptic patients
(2.3 ± 0.65 vs. 3.6 ± 0.74; p < 0.05). In the preeclamptic women undergoing vaginal delivery, 31% of them
underwent induction of labor. The most common indication for induction of labor was severity of preeclampsia
(77.8%). Birth weight was statistically significantly lower in women with preeclampsia (p < 0.0001). Among the
patients, 5.6% of them were admitted with intrauterine fetal demise, while 111 neonates survived for the
remaining patients. The most common causes of neonatal mortality were congenital abnormalities and respira-
tory distress syndrome.
Conclusion: Gestational age, parity, cesarean section rate, the rate of induced labor, and low birth weight
neonates were more frequent in preeclamptic women than in healthy pregnant women. [Taiwan J Obstet Gynecol
2007;46(3):255–259]
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■ ORIGINAL ARTICLE ■
Introduction
Hypertension is the most important disease in the
expectant mother and the fetus, and it unfavorably
affects the perinatal morbidity and mortality [1]. Hyper-
tensive complications of pregnancy are heterogeneous
in their presentation and should be considered a clini-
cal syndrome rather than a single-disease entity [2].
Preeclampsia is a pregnancy-specific hypertensive
syndrome associated with significant morbidity and
mortality in mother and neonate. With increasing
understanding of the disease process, the occurrence
of complication and the maternal and perinatal deaths
have fallen over the last few decades in the developed
countries. In other parts of the world, the rates of mor-
tality and morbidity remain high [3]. Severe preeclamp-
sia is associated with different degrees of fetal injury.
The main impact on the fetus is undernutrition as 
a result of utero-placental vascular insufficiency, which
leads to growth retardation. There are short- and long-
term effects. The immediate impact observed is altered
fetal growth resulting in greater fetal liability. Fetal
health as well as its weight are highly compromised,
leading to various degrees of fetal morbidity, and fetal
damage may be such as to cause fetal death [4].
To date, few studies have examined maternal and
neonatal complications and outcomes in preeclamp-
sia in Iran. In this study, we compared neonatal and
*Correspondence to: Assistant Professor Mandana Saadat, P.O.
Box 13185-1678, Tehran, Iran.
E-mail: swt_f@yahoo.com
Accepted: April 27, 2007
maternal complications in preeclamptic with healthy
pregnant women admitted during a 1 year period in
Bandarabbas Shariati Hospital.
Materials and Methods
We analyzed retrospectively all consecutive women with
preeclampsia during the period from July 2005 to July
2006 at Bandarabbas Shariati Hospital. Data of 125
preeclamptic women with a live singleton pregnancy
were extracted from the clinical record and hospital
data. Maternal age, body mass index, maternal weight,
systolic and diastolic blood pressures, history of ciga-
rette smoking, parity, type of delivery, causes of cesarean
section, gestational age, birth weight, and maternal and
neonatal complications and mortality were included
as study variables and were compared with 125 nor-
motensive pregnant women as control group. The two
groups were matched for age, race, date of delivery, and
distance of home from the hospital. Patients were
excluded from either group if they had hydatiform mole,
diabetes mellitus, or history of renal, cardiac or vascu-
lar diseases. Smoking during pregnancy was measured
by the number of packs smoked per day and duration
of smoking. Smoking history was positive if patients
used at least 10 cigarettes daily during the two recent
years considered. Preeclampsia was defined as the in-
crease in diastolic blood pressure (≥ 90 mmHg) and
proteinuria (≥ 1+ by dipstick testing) [5]. The Interna-
tional Classification of Diseases (ICD-10) defines pro-
longed active phase of labor as: (1) a progress of slower
than 1 cm per hour with the following codes (O62,
O62.0, O62.1); (2) irregular or poor uterine contrac-
tions with the following codes (O62.4, O62.8, O62.9);
(3) a labor with regular uterine contractions for more
than 12 hours (O63, O63.0, O63.9); and (4) a cervical
dilation of 10 cm for more than three hours (O63.1)
[6]. Grand multiparity was also defined for the study
as five or more previous births at a gestation of 20 or
more weeks [7].
The patient was evaluated every hour for vital signs,
every 10 minutes for fetal heart rate, and every 15 min-
utes for uterine contractions in the labor ward. Six
hours later, if the patient had not have at least three
contractions in 10 minutes lasting for more than 40
seconds, intravenous oxytocin was started with a dose
of 6 mU/min and increased by 6 mU/min at 40-minute
intervals until adequate uterine activity (three contrac-
tions in 10 minutes). The maximum dose of oxytocin
allowed was 42 mU/min.
Data in this study were analyzed by χ2-test and
unpaired t test using SPSS version 13. A p value of 
less than 0.05 was considered statistically significant.
Results are expressed as numbers and mean ± standard
deviation.
Results
From July 2005 to July 2006, 5,436 pregnant women
were admitted to this hospital, of which 125 were
preeclamptic patients. Demographic characteristics of
the study and control groups are shown in Table 1.
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Table 1. Demographic characteristics in preeclamptic and healthy pregnant women*
Characteristics Patient group (n = 125) Control group (n = 125) p
Maternal age (yr) 39 ± 2 37 ± 2 < 0.05
Body mass index 23.4 ± 0.9 21.3 ± 0.4 < 0.05
Weight (kg) 73.6 ± 3.2 64.6 ± 2.3 < 0.001
Systolic blood pressure (mmHg) 165 ± 5.0 125 ± 5.0 < 0.001
Diastolic blood pressure (mmHg) 108 ± 4.3 79 ± 2.5 < 0.001
Parity
1 43 39 NS
2–5 47 53 NS
≥ 6 10 8 NS
Age category
< 18 years old 14 8 NS
18–35 years old 75 79 NS
> 35 years old 11 13 NS
*Data are presented as mean ± standard deviation or percentage. NS = not significant.
The mean gestational age in the study group was
higher than that in the control group (39 ± 2 vs. 37 ± 2
gestational weeks; p < 0.05). The percentage of pre-
eclamptic and normal women who smoked cigarettes
was 4.2% and 3.9%, respectively. The mean parity in nor-
motensive patients was higher than that in preeclamptic
patients (3.6 ± 0.74 vs. 2.3 ± 0.65; p < 0.05). Of maternal
age, 75% of patients and 79% of healthy women were
aged 18–35 years, whereas age of over 35 years was
observed in 11% of patients and 13% of healthy women.
No difference in categorized ages between the two
groups was found.
Thirty percent of preeclamptic and 13% of healthy
pregnant women required cesarean section, with occur-
rence being more frequent in the patient group (p =
0.001). Different indications of cesarean section in the
two groups are shown in Table 2. The most frequent
indication of cesarean section in the preeclamptic group
was previous cesarean section (27% of patients), whereas
in normotensive women, it was fetal distress (47% of
patients).
Of the preeclamptic women undergoing vaginal
delivery, 31% of them underwent induction of labor.
The common reasons for inducing labor were severity
of preeclampsia (77.8%), premature rupture of fetal
membrane (3.8%), post-term pregnancy (3.8%), abrup-
tio placenta (3.8%), and intrauterine fetal demise (IUFD).
The mean duration of induction in the patient group
was between 3 to 17 hours. Seven pregnant women
were candidates for cesarean section because of failed
induction and severity of preeclampsia.
The birth weight was statistically significantly lower
in women with preeclampsia than in women with 
normal blood pressure (p < 0.0001). The percentage of
women with low birth weight was also different be-
tween two groups (patient group, 32% vs. control group,
4.8%; p < 0.0001).
The mean Apgar score in neonates at 1 and 5 min-
utes of the preeclamptic group were 7.6 and 8.8, respec-
tively, which were lower than for neonates of healthy
women (8.9 and 9.9 at 1 and 5 minutes, respectively).
Complications after delivery are summarized in
Table 3. According to the results, only cesarean delivery
was more frequent in preeclamptic women, and no
significant differences in other variables between the
two groups were seen.
Of the 125 preeclamptic women, seven patients
were admitted with IUFD, while 111 neonates survived
for the remaining patients. Common causes of neonatal
mortality were congenital abnormalities (eight neo-
nates), respiratory distress syndrome (six neonates), dys-
tocia (two neonates), and premature rupture of fetal
membrane (one neonate). Of the neonates with birth
weight of 1,100–2,500 g, only three were admitted to
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Table 2. Indications of cesarean section in preeclamptic and healthy pregnant women*
Indication Patient group (n = 125) Control group (n = 125)
Previous cesarean section 27 33
Fetal distress 22 47
No response to induction 19 0
Prolonged labor 11 6
Grand multiparity 11 0
Twin pregnancy 5 0
Malpresentation 5 14
*Data are presented as percentage.
Table 3. Complications of delivery in preeclamptic and healthy pregnant women*
Complications Patient group (n = 125) Control group (n = 125) p
Cesarean delivery 30 13 0.001
Blood transfusion 18.3 15.2 NS
Acute renal failure 3.6 3.2 NS
Acute respiratory distress syndrome 4.2 3.9 NS
Placental abruption 8.8 4.1 NS
Postpartum hemorrhage 4.1 1.9 NS
Pulmonary edema 2.7 1.1 NS
Neurologic complications 0.6 0.1 NS
Eclampsia 0.6 0.0 NS
*Data are presented as percentage. NS = not significant.
hospital for respiratory distress syndrome, only one of
whom was delivered by cesarean section.
Discussion
Hypertension is an important cause of both maternal
and fetal morbidity and mortality in pregnant women.
The reduction in morbidity and mortality in the treat-
ment of preeclampsia is important [8], and the high
perinatal mortality associated with this disorder has
fallen significantly [9].
In previous studies, it was concluded that women
with hypertension in pregnancy, particularly if they 
are more than 30–35 years old, overweight, and with
previous history of hypertension, must be carefully
managed by expert physicians in order to decrease the
complications [3].
The overall prevalence of hypertensive disorders of
pregnancy in this region (Bandarabbas, Iran) was
2.3%, which was comparable with the prevalence of
3.3%, 3.7%, 3%, and 2.6%, as reported by Zareian [10]
in Shiraz, Iran, Ventura et al [11] in the United States,
Al-Ghamdi et al [12] in northwest Saudi Arabia, and
Mahfouz et al [13] in southwest Saudi Arabia, respec-
tively. Although the proportion of pregnancies with
gestational hypertension and eclampsia has remained
about the same in the US over the past decade, the
rate of preeclampsia has increased by nearly one-third.
This increase is, in part, due to a rise in the numbers of
older mothers and multiple births, where preeclamp-
sia occurs more frequently [14].
Preeclampsia affects approximately 4.5–11.2% of
pregnancies in industrialized countries and occurs more
commonly in patients at the extreme ends of the repro-
ductive age range. It is seen more often in primigravida
women than in multiparous women. Recent epidemi-
ologic studies suggest that multiparous women with
different partners have a higher risk for preeclampsia
than multiparous women with the same partner, per-
haps because of a protective effect of repeated exposure
to specific antigens [15].
In this study, the frequency of cesarean section was
higher in preeclamptic women. Similarly, Al-Mulhim 
et al’s study showed that vaginal deliveries were less
frequent in women with preeclampsia (69.2%) as 
compared with healthy controls (86.2%) [16]. Also, in
Bozhinova et al’s study, normal delivery was attained
with 48.8% and cesarean section with 47.6% of the
pregnancies [1]. Witlin et al found that operative
delivery by cesarean section in pregnancies with pre-
eclampsia reduced complications to the fetus as well
as the mother [17].
In our study, the most frequent indication of cesar-
ean section in the preeclamptic group was a previous
cesarean section. Vaginal delivery is safer than cesarean
section in women with preeclampsia–eclampsia and
usually should be attempted unless there are other
obstetric indications for cesarean delivery. Certain
women at preterm gestation with severe preeclampsia
or eclampsia in whom the cervix is unfavorable for
vaginal delivery may benefit from cesarean section with-
out attempting labor induction [15]. Odegard et al
found that previous history of preeclampsia strongly
increased the risk for preeclampsia in the current preg-
nancy, and the risk of early onset preeclampsia was
especially high [5]. They showed that heterogeneous
clinical manifestations of preeclampsia might be pre-
ceded by different pathologic mechanisms.
In our study, 31% of preeclamptic women who un-
derwent vaginal delivery had undergone induction of
labor. A study showed that the hypertensive group had
high incidence of induced labor and an increased risk
for low birth weight [18].
We found that the birth weight was lower in women
with preeclampsia. Similarly, Hiett et al found that 
the mean birth weight of preeclamptic neonates was
significantly lower than that of controls [19]; on the
contrary, Xiong et al found that there were no differ-
ences in mean birth weight between women with ges-
tational hypertension and women with normal blood
pressure [20].
In this study, only 5.6% of preeclamptic women were
admitted with IUFD, whereas in Murphy et al’s study,
this complication occurred in 16% of the patients [21].
Also, our study showed that respiratory distress syn-
drome was an important cause of neonatal mortality.
In Wiltin et al’s study, it was directly related to cesarean
section, and the survival was directly associated with
birth weight [17]. In an another other study, 4.7% of
neonates died before discharge [22].
Our study had some limitations. Firstly, we did 
not adjust for confounding variables to assess the
influence of preeclampsia on maternal and neonatal
mortality and complications. Secondly, the severity of
preeclampsia was not considered as a variable in this
study.
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